Torsades de pointes and ventricular fibrillation in a canine model of quinidine-induced QT prolongation.
Inoue
H
H
Department of Internal Medicine 2, Tokyo University Hospital, Japan.
Sugimoto
T
T
D000818:Animals; D001950:Bretylium Tosylate / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial; D004285:Dogs; D005260:Female; D006329:Heart Conduction System / Q000502:physiology; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D008955:Models, Cardiovascular; D011802:Quinidine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D016171:Torsades de Pointes / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000188:drug therapy
D001950:Bretylium Tosylate; D008012:Lidocaine; D011802:Quinidine; D007545:Isoproterenol